IOVANCE BIOTHERAPEUTICS, INC. Non Peo Neo Avg Total Comp Amt
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Non Peo Neo Avg Total Comp Amt of $1.29 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-28.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-04-28
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $1.29M DEF 14A · filed 2026-04-28 |
| 2024-12-31 | $3.26M DEF 14A · filed 2026-04-28 |
| 2023-12-31 | $1.69M DEF 14A · filed 2026-04-28 |
| 2022-12-31 | $2.16M DEF 14A · filed 2026-04-28 |
| 2021-12-31 | $3.27M DEF 14A · filed 2026-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |